News | February 16, 2009

Webinar Reviews the Role of 3D ICE, Mapping in Ablation of Ventricular Outflow Tract Tachycardia

February 16, 2009 - Registration is now open for the Heart Rhythm Society’s free Reality EP Webcast, “Role of 3D ICE and Epicardial Mapping in the Ablation of Ventricular Outflow Tract Tachycardia,” at 7 p.m. EDT Wednesday, March 4.

This new Webcast will feature a panel discussion of an ablation of ventricular outflow tract tachycardia procedure utilizing 3D ultrasound, coronary venous mapping, and percutaneous epicardial mapping in determining the site of origin of the ectopic beats and in guiding ablation.

Expert faculty for this session includes William G. Stevenson, M.D., FHRS; David J. Wilber, M.D., CCDS; and Neil Brysiewicz.

Upon completion of this educational activity, participants will be able to use the surface ECG to identify potential sites of VT origin and plan optimal mapping strategies prior to the procedure. They will also recognize the differences between, and limitations of, both transvenous and percutaneous transpericardial approaches to epicardial mapping of outflow tract VT, and use 3D echo to construct anatomic mapping templates and guide ablation of outflow tract VT.

For more information: www.hrsonline.org

Related Content

First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
FDA Approves Biosense Webster's Tag-Index Guided Ablation Software
Technology | Ablation Systems | October 09, 2018
Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for its Visitag...
Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
CardioFocus Announces Successful Live Case Featuring HeartLight X3 System
News | Ablation Systems | May 17, 2018
Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during...
Imricor MRI-Guided Cardiac Ablation Study Results to Be Presented at HRS 2018
News | Ablation Systems | May 10, 2018
Results from the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Overlay Init